Biobank for Inflammatory Chronic Diseases and Osteoporosis
Recruiting · NCT05039216 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Toulouse
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
- With National Health Assurance
- Able to consent to the study
Exclusion criteria
- Pregnancy or breastfeeding
- Not able to give a consent
- Severe anemia (Hb\<10g/L)
Where it is running
3 locations listed.
- Purpan University Hospital - Toulouse, France
- Purpan University Hospital - Toulouse, France
- Purpan University Hospital - Toulouse, France